Genedrive - COV19-ID Kit

Rapid Molecular Testing, Now at Hand.
Speed - Real-time LAMP detection yields postive results as fast as 7.5 minutes, confirmed negative results in 17 minutes

Ease of Use - Simple, RNA extraction-free test with workflow similar to lateral flow tests

Rigorous - Globally accepted 2-gene targets to reduce risk of impact from emerging Variants of Concern

Sensitive - In the clinical cohort of 252 samples referenced against the Thermo Fisher TaqPath™ COVID-19 RT-PCR test the sensitivity was 98.0% (95% CI 93.1 -99.5%) and specificity 98.0% (95% CI 94.3 - 99.3%) across samples at greater than 500 copies/mL.

Near patient - Simple to use assay on maintenance-free, portable Genedrive® instrument

As the global fight against coronavirus transmission continues, there is a demand for targeted, point of need SARS-CoV-2 testing that provides higher confidence in results. The new Genedrive® COV19-ID Kit offers easy to use, rapid SARS-CoV-2 detection away from the hospital setting.

The Genedrive® COV19-ID Kit is designed for detection of the SARS-CoV-2 virus using a nasal mid-turbinate swab. The test is used on the Genedrive® instrument (GD-003)

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) granted a CTDA for sale of the Genedrive® COV19-ID Kit in the UK via the Medical Devices (Coronavirus Test Device Approvals Regulations 2021)